Published in Nat Rev Immunol on April 01, 2007
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature (2008) 10.80
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med (2011) 7.29
From vaccines to memory and back. Immunity (2010) 3.30
The influenza virus enigma. Cell (2009) 2.48
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med (2009) 2.47
H5N1 influenza viruses: facts, not fear. Proc Natl Acad Sci U S A (2012) 1.94
Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus. Mol Ther (2008) 1.84
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine (2009) 1.56
Genetic evolution of swine influenza A (H3N2) viruses in China from 1970 to 2006. J Clin Microbiol (2008) 1.52
A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. Virology (2008) 1.48
Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. Virology (2010) 1.39
Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006. Virol J (2008) 1.39
Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses. J Virol (2008) 1.34
Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level. J Biol Chem (2009) 1.28
Targeting B cell responses in universal influenza vaccine design. Trends Immunol (2011) 1.27
A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J Virol (2010) 1.26
Preparedness for highly pathogenic avian influenza pandemic in Africa. Emerg Infect Dis (2007) 1.25
Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets. Vaccine (2011) 1.20
Complete genome sequence analysis of an H6N1 avian influenza virus isolated from Guangxi pockmark ducks. J Virol (2012) 1.18
Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. PLoS Pathog (2009) 1.18
Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization. J Virol (2009) 1.17
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets. Vaccine (2011) 1.12
Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness. MBio (2014) 1.10
Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets. J Virol (2008) 1.10
Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets. Vaccine (2009) 1.09
p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J Immunol (2011) 1.08
Influenza vaccines: challenges and solutions. Cell Host Microbe (2015) 1.05
Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS One (2008) 1.04
Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets. J Virol (2014) 1.04
An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza Other Respir Viruses (2012) 1.03
Increased susceptibility for superinfection with Streptococcus pneumoniae during influenza virus infection is not caused by TLR7-mediated lymphopenia. PLoS One (2009) 1.02
Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx mori. PLoS One (2008) 1.01
Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium. J Virol (2012) 0.99
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine (2011) 0.99
Fine epitope mapping of monoclonal antibodies against hemagglutinin of a highly pathogenic H5N1 influenza virus using yeast surface display. Biochem Biophys Res Commun (2011) 0.93
Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody. J Virol (2014) 0.93
Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness. PLoS One (2013) 0.93
Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus. PLoS One (2011) 0.92
Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. Expert Rev Vaccines (2009) 0.92
H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines. PLoS One (2009) 0.91
Complete genomic sequence of a novel natural recombinant H6N2 influenza virus from chickens in Guangdong, Southern China. J Virol (2012) 0.90
Enhanced immunogenicity, mortality protection, and reduced viral brain invasion by alum adjuvant with an H5N1 split-virion vaccine in the ferret. PLoS One (2011) 0.88
Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination. Immunology (2014) 0.88
Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses (2009) 0.87
MegaRibavirin aerosol for the treatment of influenza A virus infections in mice. Antiviral Res (2008) 0.85
Genetic content of Influenza H3N2 vaccine seeds. PLoS Curr (2010) 0.84
Developing vaccines to combat pandemic influenza. Viruses (2010) 0.84
Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice. Virol J (2013) 0.83
Theoretical investigation on the binding specificity of sialyldisaccharides with hemagglutinins of influenza A virus by molecular dynamics simulations. J Biol Chem (2012) 0.83
Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines. Immune Netw (2015) 0.82
Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model. Vaccine (2016) 0.81
Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets. PLoS One (2015) 0.81
Globally visualizing the microtubule-dependent transport behaviors of influenza virus in live cells. Anal Chem (2014) 0.79
B Cells and Functional Antibody Responses to Combat Influenza. Front Immunol (2015) 0.79
The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza. Front Immunol (2016) 0.79
Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice. PLoS One (2013) 0.79
Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain. Genome Med (2015) 0.79
CAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferrets. PLoS One (2011) 0.78
Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection. J Virol (2016) 0.78
Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice. Microb Cell Fact (2015) 0.77
Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions. Bioinform Biol Insights (2016) 0.76
An infected chicken kidney cell co-culture ELISpot for enhanced detection of T cell responses to avian influenza and vaccination. J Immunol Methods (2014) 0.76
Isolation and complete genomic characterization of H1N1 subtype swine influenza viruses in southern China through the 2009 pandemic. Virol J (2011) 0.75
Protective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase. BMC Vet Res (2015) 0.75
A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV. J Virol (2013) 0.75
Phylogenetic diversity and genotypic complexity of H1N1 subtype swine influenza viruses isolated in mainland China. Virol J (2012) 0.75
Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing. Med Microbiol Immunol (2013) 0.75
Full-Genome Sequence Analysis of a Natural Reassortant H4N2 Avian Influenza Virus Isolated from a Domestic Duck in Southern China. Genome Announc (2014) 0.75
Prior infection of chickens with H1N1 or H1N2 avian influenza elicits partial heterologous protection against highly pathogenic H5N1. PLoS One (2012) 0.75
Sensitization with vaccinia virus encoding H5N1 hemagglutinin restores immune potential against H5N1 influenza virus. Sci Rep (2016) 0.75
Avian-derived and human, seasonal-derived hemagglutinin proteins elicit CD4 T cell responses that are comparable in epitope abundance and diversity. Clin Vaccine Immunol (2017) 0.75
Pandemic (H1N1) 2009 infection in swine herds, Manitoba, Canada. Emerg Infect Dis (2010) 2.73
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults. J Infect Dis (2009) 1.40
Infectious salmon anemia virus: causative agent, pathogenesis and immunity. Anim Health Res Rev (2004) 0.98
Characterization of gene expression on genomic segment 7 of infectious salmon anaemia virus. Virol J (2007) 0.89